A detailed history of Magnetar Financial LLC transactions in Repligen Corp stock. As of the latest transaction made, Magnetar Financial LLC holds 1,490 shares of RGEN stock, worth $212,220. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,490
Holding current value
$212,220
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.79 - $167.35 $178,487 - $249,351
1,490 New
1,490 $221,000
Q2 2023

Aug 11, 2023

BUY
$138.42 - $180.31 $17,440 - $22,719
126 Added 8.02%
1,698 $240,000
Q1 2023

May 15, 2023

SELL
$154.26 - $198.1 $522,015 - $670,370
-3,384 Reduced 68.28%
1,572 $264,000
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $804,953 - $1.09 Million
4,956 New
4,956 $839,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.9B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.